Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF and PRP injections for wound healing after breast reduction
NL-OMON45942Withdrawn
- Sponsor
- University Medical Center Groningen
- Start
- Feb 2019
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Randomised, double-blind trial of autologous adipose stromal vascular fraction and platelet-rich plasma in Not applicable and pathological scarring (PS) (4 arms), sponsored by University Medical Center Groningen. Primary endpoint: Patient-reported scar assessment (POSAS patient scale). Planned start Feb 2019; status: withdrawn.
02
Drugs
autologous adipose stromal vascular fractionplatelet-rich plasma
03
Conditions
Not applicablepathological scarring (PS)
Beyond the preview
Go deeper on NL-OMON45942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45942.